Tempest Therapeutics Inc

NASDAQ:TPST   1:32:06 PM EDT
1.69
0.00 (-0.29%)
Earnings Announcements

Tempest Reports Q3 Financial Results, Provides Business Update

Published: 11/08/2022 14:04 GMT
Tempest Therapeutics Inc (TPST) - Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update.
Tempest Therapeutics Inc Q3 Loss per Share $0.66.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.76

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.69

More details on our Analysts Page.